drug therapy for Parkinson's, urinary spasticity, and disorders requiring anticholinergic drug therapy Flashcards
define parkinson’s disease
what is it and what is it characterized by?
-chronic, progressive, degenerative disorder of the CNS
-characterized by resting tremor, bradykinesia, rigidity, and postural instability
describe the etiology of parkinsons disease
cause of the nerve cell damage is unknown
describe the pathophysiology of parkinson’s disease
where and what neurotransitters are involved?
-progressive destruction of or degerative changes in dopamine producing nerve cells in the substantia nigra in the basal ganglia
-decrease in dopamine and increase in acetylcholine
describe the clinical manifestations of parkinsons disease
-pill rolling movements
-bradykinesia (slow movement)
-akinesia (no movement)
-shuffling gait/stooped posture
-masklike facial expressions/rigidity
-soft voice
what drug therapy is used for patients with parkinson’s disease
dopamine receptor agonsists and COMT inhibitors
-goal is to balance dopamine and acetylcholine
describe levodopa-carbidopa
two meds in one - why?
-most common used for parkinsons
-levodopa changes to dopamine in the brain, carbidopa prevents the breakdown of levodopa in the blood
-this helps correct the neurotransmitter imbalance in the brain
describe the pharmacokinetics of levodopa-carbidopa
-well absorbed in small intestine after oral administration
-primarily excreted in the urine
describe the action of levodopa-carbidopa
-increases the amount of dopamine in the brain
-levodopa is the metabolic precursor of dopamine
describe the use of levodopa-carbidopa
-dopamine receptor agonists
-symptomatic treatment of idiopathic parkinsons, often akinetic symptoms
-tx of serious restless leg syndrome
describe some adverse effects of levodopa-carbidopa
-CNS -> headache, anxiety, drowsiness, hallucinations
-cardiovascular -> orthostatic hypotension, increase or decrease in HR, decrease in BP
-GI -> anorexia, N+V, teeth grinding
-others
what are some contraindications of levodopa-carbidopa
-hypersensitivity, narrow angle glaucoma, melanoma, peptic ulcer disease, HTN
-severe cardiovascular, pulmonary, renal, hepatic, endocrine disorders
what are some nursing implications with levodopa-carbidopa
-preventing interactions
-administering medication
-assessing for therapeutic and adverse effects (know baseline HR and BP and check periodically)
-patient teaching
what are some parts of patient teaching that should be mentioned with levodopa-carbidopa
-do not stop abruptly, must be tapered off
-stop all MAOIs -> cause risk for hypertensive crisis
-do not crush, must be swallowed whole
-can be given with food
-no iron vitamins or increased protein in diet
what are some other drugs in the same class as levodopa-carbidopa
and what consideration should be made?
-amantadine, pramipexole, ropinirole, selegeline
-must be given in conjunction with levodopa-carbidopa
what is the black box warning for levodopa-carbidopa
and what should be checked?
-risk for fulminant fatal acute renal failure
-check BUN, GFR, creatinine, as well as urine output characteristics
why should you check BUN, creatinine, and GFR of a person taking levodopa-carbidopa
all indicators of renal function/failure
black box warning on med is acute renal failure
describe ropinirole
drug class? action? concentration? half life?
-stimulates dopamine receptors in the brain
-same class as levodopa-carbidopa
-steady state concentration on approx 2 days
-40% protein bound
-1/2 life elimination = 6 hours
can ropinirole be taken with levodopa-carbidopa
-yes
-especially when levopa becomes less effective, have to decrease levodopa dose when adding this medication
describe the pharmacokinetics of ropinirole
-well absorbed orally (peak level 1-2 hours)
-metabolized by cytochrome P450 (liver) (pts with hepatic impairment - increase adverse effects)
-renal excretion (alter dose in patients with renal impairment/failure)
describe COMT
what does it play a role in?
plays a role in the metabolism of dopamine and the breakdown of 10% of lepodopa in the body
should tolcapone be given by itself?
like with no other drugs?
nope. tolcapone has to be given with levodopa-carbidopa as an adjunct or add-on therapy
what if tolcapone doesnt work for a patient after three weeks?
discontinued due to the undesirable side effects, but not stopped abruptly bc it has to be tapered off over 2 weeks
describe the pharmacokinetics of tolcapone
-absorbed rapidly and is highly protein bound
-metabolized in the liver
-crosses the placenta
-excreted in the feces and urine
also has 2-3 hour half life
describe the action of tolcapone
inhibits the metabolism of levodopa in the bloodstream, may also inhibit COMT in the brain and prolong the activity of dopamine at the synapse
what is tolcapone used for?
treatment of the signs and symptoms of idiopathic parkinsons disease
what are the adverse effects associated with tolapone
-CNS = disorientation, confusion, hallucination, and psychosis
-cardiovascular = othrostatic hypotension
-GI very sudden severe liver failure
-respiratory
-generalized
look at ALT/AST lab results bc they indicate liver function